Cancer Economics and Benchmarking WG
Chairperson: Wim H. van Harten
The OECI is proud to announce the constitution of a Cancer Economics and Benchmarking Working Group that will facilitate careful and explicit balancing of clinical benefits adn financial impact of cancer treatments. The primary objectives of the WG will be to demonstrate remits of cost-benefits analyses in oncology and to estabilish standards in budget impact analysis for OECI members. The WG will also pay attention to those recent developments in health economics, for example value based pricing, budget impact expertise, which have the special interest of the members. An interest call will be sent out soon to all members for their input.